Affymax, Inc. (NASDAQOTH:AFFY)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 1/4/2013 10:20:40 AM : Outperform Start Price: $20.53 AFFY Score: -6.29

somewhat optomistic at least in the near term

Featured Broker Partners


Advertisement